PHASE-I STUDY OF ANTILIPOPOLYSACCHARIDE HUMAN MONOCLONAL-ANTIBODY MAB-T88

被引:12
|
作者
DAIFUKU, R [1 ]
HAENFTLING, K [1 ]
YOUNG, J [1 ]
GROVES, ES [1 ]
TURRELL, C [1 ]
MEYERS, FJ [1 ]
机构
[1] CHIRON CORP,1400 53RD ST,EMERYVILLE,CA 94608
关键词
D O I
10.1128/AAC.36.10.2349
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Monoclonal antibody MAB-T88 is a human monoclonal immunoglobulin M antibody directed at the lipopolysaccharide of gram-negative bacteria. In this study, nine patients who were expected to become neutropenic from antineoplastic chemotherapy received an infusion of MAB-T88, three patients at each of three doses: 1, 4, and 8 mg/kg of body weight. MAB-T88 was shown to be safe, with an effective half-life in plasma of 25.4 h, and no patient developed immunoglobulin G antibody to MAB-T88.
引用
收藏
页码:2349 / 2351
页数:3
相关论文
共 50 条
  • [1] PHASE-I STUDY OF ANTI-LIPID A HUMAN MONOCLONAL-ANTIBODY MAB-T88
    DAIFUKU, R
    HAENFTLING, K
    GROVES, E
    TURRELL, C
    MEYERS, F
    CLINICAL RESEARCH, 1991, 39 (02): : A438 - A438
  • [2] PHASE-I STUDY ON HUMAN MONOCLONAL-ANTIBODY AGAINST CYTOMEGALOVIRUS - PHARMACOKINETICS AND IMMUNOGENICITY
    AZUMA, J
    KURIMOTO, T
    TSUJI, S
    MOCHIZUKI, N
    FUJINAGA, S
    MATSUMOTO, Y
    MASUHO, Y
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (04) : 278 - 285
  • [3] A PHASE-I STUDY OF MONOCLONAL-ANTIBODY THERAPY IN DISSEMINATED MELANOMA
    LICHTIN, AE
    GUERRY, D
    ELDER, DE
    HAMILTON, R
    LAROSSA, D
    HERLYN, D
    ILIOPOULOS, D
    THURIN, J
    STEPLEWSKI, Z
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 87 (03) : 426 - 426
  • [4] PHASE-I RADIOIMMUNOTHERAPY (RAIT) USING A RHENIUM-188-LABELED MURINE MONOCLONAL-ANTIBODY (MAB)
    SHARKEY, RM
    GOLDENBERG, DM
    LEVINE, G
    VAGG, R
    AHMAD, M
    PAWLYK, D
    SIEGEL, JA
    GRIFFITHS, GL
    HANSEN, HJ
    CALLAHAN, AP
    KNAPP, FF
    SWAYNE, LC
    CONTE, PJ
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P54 - P54
  • [5] PHASE-I TRIAL AND PHARMACOKINETICS OF A HUMAN-IGM MONOCLONAL-ANTIBODY TO ENDOTOXIN (LPS)
    KHAZAELI, M
    KUBAGAWA, H
    TENG, N
    ZIEGLER, E
    ROGERS, K
    PETERSON, L
    SALEH, M
    BOGARD, C
    CARRANO, R
    BERGER, H
    LOBUGLIO, A
    CLINICAL RESEARCH, 1987, 35 (03): : A615 - A615
  • [6] PHARMACOKINETICS OF F105, A HUMAN MONOCLONAL-ANTIBODY FOR THE TREATMENT OF HIV-INFECTION - A PHASE-I STUDY
    WOLFE, EJ
    CAVACINI, LA
    POSNER, MR
    SAMORE, MH
    SPINO, C
    KETTER, N
    TRAPNELL, C
    HAMMER, S
    GAMBERTOGLIO, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 143 - 143
  • [7] PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF SUPPRESSION OF HUMAN ANTIMOUSE ANTIBODY-RESPONSE TO MONOCLONAL-ANTIBODY L6 BY DEOXYSPERGUALIN
    DHINGRA, K
    FRITSCHE, H
    MURRAY, JL
    LOBUGLIO, AF
    KHAZAELI, MB
    KELLEY, S
    TEPPER, MA
    GRASELA, D
    BUZDAR, A
    VALERO, V
    BOOSER, D
    WHEALIN, H
    COLLINS, TJ
    PURSLEY, JM
    HORTOBAGYI, G
    CANCER RESEARCH, 1995, 55 (14) : 3060 - 3067
  • [8] PHASE-I CLINICAL-TRIAL OF MONOCLONAL-ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMORS
    SEARS, HF
    ATKINSON, B
    MATTIS, J
    ERNST, C
    HERLYN, D
    STEPLEWSKI, Z
    HAYRY, P
    KOPROWSKI, H
    INNERE MEDIZIN, 1982, 9 (06) : 297 - 299
  • [9] PILOT-STUDY OF ANTI-LPS HUMAN MONOCLONAL ANTIBODY-MAB-T88
    DAIFUKU, R
    HAENFTLING, K
    SWENSON, WK
    PRESCOTT, AM
    JOHNSON, JL
    PANACEK, EA
    CLINICAL RESEARCH, 1992, 40 (01): : A122 - A122
  • [10] PHASE-I CLINICAL-TRIAL OF MONOCLONAL-ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMORS
    SEARS, HF
    MATTIS, J
    HERLYN, D
    HAYRY, P
    ATKINSON, B
    ERNST, C
    STEPLEWSKI, Z
    KOPROWSKI, H
    LANCET, 1982, 1 (8275) : 762 - 765